Page last updated: 2024-08-21

fluorobenzenes and Experimental Spinal Cord Ischemia

fluorobenzenes has been researched along with Experimental Spinal Cord Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Die, J; Fan, L; Jiang, Y; Shi, Z; Wang, K	1

Other Studies

1 other study(ies) available for fluorobenzenes and Experimental Spinal Cord Ischemia

Article	Year
Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain research, 2010, Jul-30, Volume: 1346 Topics: Animals; Biomarkers; Blotting, Western; Fluorobenzenes; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Infarction; Ischemic Preconditioning; Locomotion; Male; Mevalonic Acid; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Spinal Cord Ischemia; Sulfonamides; Treatment Outcome	2010

Article

Year

Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.

Brain research, 2010, Jul-30, Volume: 1346

Topics: Animals; Biomarkers; Blotting, Western; Fluorobenzenes; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Infarction; Ischemic Preconditioning; Locomotion; Male; Mevalonic Acid; Neuroprotective Agents; Nitric Oxide Synthase; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Spinal Cord Ischemia; Sulfonamides; Treatment Outcome

2010